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Abstract.  The receptor for asialoglycoproteins 
(ASGPR) was localized in human hepatoma Hep G2 
cells by means of quantitative immunoelectron micros- 
copy. Without ligand added to the culture medium, we 
found 34 % of the total cellular receptors on the 
plasma membrane, 37 % in compartment of uncoupling 
receptor and ligand (CURL), and 21%  in a trans-Golgi 
reticulum (TGR)  that was defined by the presence of 
albumin after immuno-double labeling. A small per- 
cent of the ASGPR was associated with coated pits, 
the Golgi stacks,  and lysosomes. After incubation of 
the cells with saturating concentrations of the ligand 
asialo-orosomucoid (ASOR), the number of cell sur- 
face receptors decreased to 20%  of total cellular 
receptors, whereas the receptor content of CURL in- 
creased by a corresponding amount to 50%.  The 
ASGPR content of TGR remained constant. In con- 
trast, after treatment of the cells with 300 ~tM of the 
weak base primaquine (PMQ), cell surface ASGPR 
had decreased dramatically to only 4%  of total cellular 
receptors whereas label in the TGR had increased to 
42 %.  ASGPR labeling of CURL increased only to 
47 %.  The labeling of other organelles remained un- 
changed. This affect of PMQ was independent of the 
presence of additional ASOR. Implications for the in- 
tracellular pathway of the ASGPR are discussed. 
IVER parenchymal  cells  possess  cell  surface  receptors 
that function in the clearance of galactose-terminated 
glycoproteins from the circulation  (1,  17). In addi- 
tion, these asialoglycoprotein receptors (ASGPR)  1  are pres- 
ent in abundance on the human hepatoma cell line Hep G2 
that contains •225,000  high affinity ligand-binding sites per 
cell (22, 23). In Hep G2 cells not exposed to ligand a con- 
siderable  fraction  of the functional ligand-binding sites is 
located on the cell surface (21). However, the presence  of 
ligand (e.g., asialoorosomucoid [ASOR]) in the extracellular 
fluid promotes a relative increase in the fraction of receptors 
located intracellularly  (4, 23). 
Lysosomotropic amines,  which accumulate within intra- 
cellular acidic organelles (5) thereby neutralizing the inter- 
nal pH (18, 33), alter the intraceUular distribution of several 
receptor  species.  The number of surface-binding  sites for 
LDL (2), mannose-(29) and mannose-6-phosphate-(13) ter- 
minated ligands, alpha-2 macroglobulin (15), and asialogly- 
coproteins (21, 28) is markedly reduced after incubation with 
these agents. This reduction was seen in both the presence 
and absence of added ligand. However, in several cases the 
1. Abbreviations used in this paper: ASGPR, asialoglycoprotein  receptor; 
ASOR,  asialo-orosomucoid;  CURL, compartment of uncoupling receptor 
and ligand;  MVB,  multi-vesicular  body; PMQ,  primaquine; TGR,  trans- 
Golgi reticulum. 
effect was enhanced in the presence ofligand (2, 15, 21). This 
loss of cell  surface-binding  sites is  reversible since after 
removal of  the agent the cell surface ligand-binding capacity 
is rapidly and fully restored  (21, 29).  These observations 
suggest that  the  receptors  accumulate  intracellularly  in a 
nonlysosomal compartment.  The aim of this study is to es- 
tablish the morphologic identity of this compartment after 
treatment of the cells with ligand, a lysosomotropic amine, 
or with both. 
We have reported a dose-dependent and reversible loss of 
surface ASGPR in Hep G2 cells treated with primaquine 
(PMQ) or other lysosomotropic amines (21, 28).  The cells 
were found to possess a well-developed endocytotic appara- 
tus  including  compartment  of uncoupling  receptor  and 
ligand (CURL) (8,  11). Using immunoelectron microscopy 
and antibodies against PMQ, we found that PMQ accumu- 
lates  in  CURL,  including  multivesicular  bodies  (MVB), 
lysosomes, and in the Golgi complex (25). 
In the present study we used quantitative immunoelectron 
microscopy  to  describe  the  intracellular  localization  of 
ASGPR in Hep G2 cells,  and examined the effects of the 
ligand  ASOR  and  of PMQ  on receptor  distribution.  We 
found that ASOR induced a partial redistribution of recep- 
tors from the plasma membrane to CURL. PMQ however, 
caused a dramatic disappearance of receptors from the cell 
surface in favor of trans-Golgi reticulum (TGR). 
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Materials 
Human  orosomucoid  was  provided  by  the  American  Red  Cross  and 
desialylated as described earlier (24). PMQ as the biphosphate was obtained 
from Sigma Chemical Co. (St. Louis, MO). Rabbit antibody to the human 
ASGPR was affinity purified as described earlier (20). Rabbit anti-human 
albumin  (Nordic  Immunology,  Tilburg,  The  Netherlands)  was  affinity 
purified on an albumin ultrogel column. Rabbit anti-cathepsin D (14) was 
a kind gift of Drs. K. von Figura and A. Hasilik (University of Miinster, 
Federal Republic of German!c).  Uniformly-sized protein A-gold complexes 
of 8 and 5 nm were prepared according to the tannic-acid procedure as de- 
scribed (27). 
Cells 
Human hepatoma Hep G2 cells (16), clone a  16,  were maintained as de- 
scribed previously (22).  Confluent cultures were used in all experiments. 
Experimental Procedures 
Hep G2 cells were washed twice in MEM and cultured in MEM containing 
10% normal rabbit serum for 4 h at 37°C. All cells were washed again and 
preincubated for 30-60 min at 37°C in MEM supplemented with 20 mM 
Hepes (pH 7.4). Thereafter, control cells that received no additional supple- 
ments were maintained in MEM-Hepes for 40 min at 37°C.  Cells exposed 
to ligand only were incuba~d with medium containing 200 Ixg ASOR/ml 
for 40 min at 37°C. Cells exposed to PMQ only were incubated in medium 
containing 300 I~M PMQ for 30 rain at 37°C. Cells exposed to both ligand 
and PMQ were first incubated for 10 min at 37°C with ASOR alone, after 
which PMQ was added for the final 30 min at 37°C. 
Processing  for Immunocytochemistry and Morphology 
After the appropriate incubations the cells were fixed in 2 % glutaraldehyde 
in 0.05 M phosphate buffer at pH 7.4 for 4 h at room temperature. Cells 
were then scraped from the dish and embedded in gelatin as previously de- 
scribed (6). The gelatin blocks were stored at 4°C for several weeks in 0.1 M 
phosphate buffer containing 0.02 % sodium azide. Blocks were immersed in 
2.3 M sucrose and frozen in liquid nitrogen. Cryosections were prepareti 
according to Tokuyasu  (32). Immuno-double labeling of sections was per- 
formed as previously described in detail (12). Anti-human albumin antise- 
rum was used in the first step, followed by protein A-gold. Anti-ASGPR was 
used as the second antibody, followed by protein A-gold of a different di- 
ameter. In double labeling of  the ASGPR with cathepsin D, anti-ASGPR was 
used in the first step. Sections were stained with uranyl acetate and embed- 
ded in methyl cellulose according to Tokuyasu  (31). 
Normal cells and cells treated with 300 IxM PMQ for 30 min were fixed 
with 2% glutaraldehyde in 0.1 M cacodylate buffer, embedded in 1% agar 
in distilled water at 70°C, and postfixed in 1% osmiumtetroxyde in distilled 
water.  Agar blocks were dehydrated in alcohol and embedded in epon. 
Ultrathin sections were stained with 7 % uranylacetate in methanol and 0.4 % 
leadcitrate in 0.1  M  sodiumhydroxide. 
Quantitation of  Receptors 
Three independent experiments were performed. Of several series of grids, 
sections were  selected that  exhibited good morphology.  Approximately 
1,000-2,000  gold particles labeling the ASGPR were counted for each of 
the three experiments. This represented ,vl00 cells per experiment, dis- 
tributed over at least three grids. The particles were counted directly from 
the microscope screen. At low magnification the electron beam was placed 
in the top left comer of a grid mesh. After enlarging the magnification to 
15,000×  the grid was moved in one direction to the other side of the mesh. 
Thus the cells were encountered in a nonselective manner. The numbers of 
gold particles within each cell compartment (Table I) were expressed as the 
percentage of the total  number of gold particles counted. The number of 
measurements required for a statistically reliable sample was determined by 
progressive mean analysis (3).  15 cell cross sections appeared to represent 
a reliable sample. Limits of confidence were 5 % or less for at least the final 
three samples. 
Determination of  ASOR-binding Sites 
Quantitation of specific cell surface ~25I-ASOR binding was determined at 
4°C as described previously (22). The total cell number of ligand-binding 
sites was determined by specific ~25I-ASOR binding to cells at 4°C after 
permeabilization with saponin for 30 min at 4°C (26).  In experiments in 
which cells were preincubated with nonradioactive ASOR, the cells were 
incubated for 5 rain at 4°C with PBS containing no calcium but containing 
5 mM EDTA at pH 5 to remove ligand from the receptor before saturation 
binding with 125I-ASOR (26). 
Results 
Localization of  ASGPR in Ligand-Naive Hep G2 Cells 
The normal localization of ASGPR was  studied in "ligand- 
naive" cells,  i.e.,  cells that had been cultured in medium 
without additional serum or ligand, and is shown in Figs.  1 
and 2. ASGPR labeling occurred diffusely along the entire 
plasma membrane but was most abundant at the surface fac- 
ing the culture medium. Receptors were concentrated in pe- 
ripheral coated pits and vesicles. CURL was heavily labeled 
(Fig. 2). Double labeling with cathepsin D showed that some 
ASGPR-positive MVBs were poorly labeled for cathepsin D 
while others showed abundant cathepsin D labeling but did 
not label significantly for the ASGPR (not shown). This is 
in accordance with our observation that ASGPRs are present 
in newly formed CURL vacuoles but sort out from older 
ones into the CURL tubules (7).  Typical secondary lyso- 
somes showed only an occasional ASGPR label. In contrast 
to the situation in rat liver (9), only a little ASGPR was found 
in the Golgi stack (Figs.  1 and 2).  TGR showed moderate 
ASGPR labeling (Figs.  1 and 2). 
In general CURL and TGR could easily be distinguished 
morphologically. Although both contain anastomosing tu- 
bules and vesicles, TGR displayed a more heterogenous ap- 
pearance and electron density, and showed more coated buds 
than did CURL (see also 8). Generally CURL occupied a 
peripheral position in the cells (Fig.  2) whereas TGR oc- 
curred adjacent to the Golgi complex deeper in the  cell. 
However,  some  CURL  elements could be  detected close 
to  a  Golgi complex in  the  vicinity of the  plasma  mem- 
brane.  This hampered a  sharp distinction between CURL 
and TGR. Therefore an additional parameter was used, the 
presence of secretory albumin in TGR but not in CURL (8). 
Under the incubation conditions used, possible endocytosed 
albumin was  not detected in CURL.  Only the biosynthetic 
pathway including TGR was labeled for albumin. In the sec- 
tions  double labeled with  anti-albumin  and  anti-ASGPR, 
ASGPR was distributed heterogeneously in the TGR. Some 
elements were enriched in ASGPR whereas others were de- 
void of it (Figs.  1 and 2). ASGPR-labeling of dense-coated 
Figures 1 and 2.  (Fig.  1) Immunoelectron micrograph of ligand-naive Hep G2 cell incubated without PMQ. The cryosection was immuno- 
double labeled for albumin with  10 nm gold and ASGPR with 6  nm gold particles.  Both albumin and ASGPR are present in the stack 
of Golgi cisternae (G) and TGR elements (T).  Note the heterogenous distribution of the receptors in TGR.  Bar, 0.25  ~tm.  (Fig. 2) Like 
Fig.  1. The Golgi cisternae (G) and TGR (T) contain both albumin and ASGPR in contrast to a CURL vacuole (C) that characteristically 
shows ASGPR only. P, plasma membrane. Bar,  0.25  Ixm. 
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have previously found with  the  receptor for  mannose-6- 
phosphate residues (8). 
Quantitative Distribution of  ASGPR in 
Ligand-Naive  Cells 
To determine the quantitative distribution of the receptors, 
we counted the number of gold particles confined to the vari- 
ous organelles as described in Materials and Methods. Par- 
ticle counts were expressed as a percentage of the total num- 
ber of gold particles evaluated. In ligand-naive cells (first 
column of Table I) the three plasma membrane domains to- 
gether (lateral, bile canalicular, and those facing the culture 
medium and dish bottom) accounted for "ol/3 of the cells' 
ASGPR label.  Coated pits of the plasma membrane were 
evaluated  separately.  No  distinction  was  made  between 
coated pits and vesicles. Together they contained "o5 % of the 
label. CURL and TGR contained 37 and 21% of the total cel- 
lular receptor, respectively. Lysosomes contained <1% of the 
ASGPR labeling.  The Golgi stack represented only a  few 
percent of the label. The rough endoplasmic reticulum, the 
nuclear envelope, the mitochondria, and the nuclei were un- 
labeled.  Control sections incubated with antibodies to rat 
amylase  and  rat  IgA  or with  protein A-gold alone,  gave 
negligible background values. 
Effect of  Ligand Administration on 
ASGPR Distribution 
We compared ligand-naive cells with cells exposed to ligand. 
For this purpose Hep G2 cells were washed and preincubated 
for 30-60 min in medium without additional ligand or se- 
rum. Thereafter cells were incubated for 40 min at 37°C in 
the continuous presence of receptor-saturating concentra- 
tions of ASOR. 
Cell  morphology  was  not  affected  by  treatment  with 
ASOR. However receptor distribution was altered. The sec- 
ond column of Table I  shows that receptor labeling of the 
plasma membrane declined from 34 to 20%. Labeling of pe- 
ripheral coated pits and vesicles was not affected. The recep- 
tors lost from the surface appeared to accumulate exclusively 
on the endocytotic pathway, i.e., 13 % in CURL, of which 5 % 
was in MVBs. Receptor labeling of the Golgi complex and 
lysosomes remained unaltered. 
Table L Relative Distribution of  ASGPR in Hep G2 Cell 
Compartments as Determined Morphologically 
-PMQ  -PMQ  +PMQ  +PMQ 
-ASOR  +ASOR  -ASOR  +ASOR 
Plasma membrane  34  20  4  4 
Coated pits/vesicles  5  5  1  1 
CURL  37  50  47  46 
TGR  21  22  42  46 
Golgi stack  2  2  3  1 
Lysosomes  1  1  3  2 
Cells were washed and precincubated in serum-free medium for 30-60  min at 
37°C. ASOR was added to -+ and ++ while the cells were kept at 37°C,  10 
min later PMQ was added to +- and ++. Incubation continued for 30 min. 
Cells were fixed and treated for immunoelectron microscopy. The numbers of 
gold particles present  in the various cellular compartments were counted and 
expressed as percentages of the total number of gold particles. The values are the 
mean of three experiments. The limits of confidence are 5 % as determined by 
progressive  mean analysis. 
Effect of  PMQ Treatment on ASGPR Distribution 
We have previously demonstrated (21) that incubation of Hep 
G2 cells with PMQ results in a considerable and reversible 
loss of cell surface ASOR-binding sites. In the present study 
we incubated cells with  300  gM PMQ for 30 min as de- 
scribed in Materials and Methods and quantitated the recep- 
tor redistribution. 
Morphologically PMQ treatment was manifested in a dis- 
appearance of  most of  the microvilli on the cell surface (Figs. 
5 and 6). The resulting change in cell shape, probably from 
the loss of surface membrane, was accompanied by an im- 
pressive increase in the number of intracellular tubules and 
vesicles,  especially in the Golgi region.  The Golgi com- 
plexes were more irregularly shaped and less contiguous. 
Golgi cisternae and TGR were often swollen (Figs. 3 and 4). 
MVBs and lysosomes were enlarged and more numerous. 
The MVBs showed a more electron-lucent appearance and 
were negative for cathepsin D. As a result of the increase in 
the number of tubules and vesicles, the morphological dis- 
tinction between the tubules of CURL and TGR was  less 
clear than  in  controls.  More frequently than  in  controls, 
albumin-negative but receptor-containing CURL tubules oc- 
curred in the Golgi region close to the albumin-positive TGR 
elements. 
After PMQ incubation the distribution of the ASGPR over 
the  cell organelles changed dramatically as  shown in the 
third column of Table I. ASGPR surface label decreased to 
<5 % of the control value and a significant decrease of the 
labeling of peripheral coated pits and vesicles was  found. 
This was accompanied by a considerable increase of ASGPR 
in TGR from 21% in control cells to 42%. As in control cells, 
the distribution of ASGPR in TGR was  not homogeneous 
(Fig. 5) and coated buds of TGR were not labeled. Labeling 
of CURL increased by 10 %. Double labeling with cathepsin 
D showed that lysosomes were not involved in this increase. 
Labeling of the Golgi stack had not changed significantly. 
The combined effects of 300  ~tM  PMQ  and  saturating 
amounts of ligand on ASGPR distribution are shown in the 
fourth column of Table I. There was no significant difference 
in relative distribution of ASGPR between ceils exposed to 
PMQ alone and cells exposed to both PMQ and ligand. 
Effects of PMQ on Distribution of  ASOR-binding Sites 
We next determined biochemically the number of ASOR- 
binding sites at the cell surface relative to the total cellular 
ASOR-binding sites in control cells or cells exposed to either 
ligand, or PMQ, or both (Table II). In eight independent ex- 
periments the surface ASOR-binding sites were found to be 
41 +  11% (SD) (range 26-64%) of total cell ASOR-binding 
sites.  As seen in Table II, the total cell receptor content was 
unaltered by incubation with either 300 gM PMQ, or 200 ~tg/ 
ml  ASOR,  or both.  However, the  amount of cell surface 
receptor was reduced significantly in all three cases. In the 
presence of ASOR alone, surface receptor was reduced by 
50 to 22 % of total cell receptor. In the presence of PMQ 
alone, surface receptor was reduced by 65 to 15 % of total cell 
receptor. 
Discussion 
We have recently described the localization of the ASGPR 
in rat liver hepatocytes and quantified the receptor distribu- 
The Journal of Cell Biology, Volume  104, 1987  1650 Figures 3 and 4. (Fig. 3) Golgi stack (G) and TGR (T) of Hep G2 cell incubated in the presence of 300 ~tM PMQ and saturating concentra- 
tion of ASOR for 30 min. Label of both ASGPR and albumin are present in the swollen TGR profiles (T). G, Golgi cisternae.  Bar, 0.25 
lam. (Fig. 4) Like Fig. 3 but single labeled with 10 Ixm gold for the presence of ASGPR to show the intense labeling ofTGR (T) as compared 
with the Golgi cisternae  (G). As in many cells, the Golgi cisternae  are swollen as a result of PMQ treatment.  Bar, 0.25  I.tm. 
tion (9). There is a close similarity in distribution between he- 
patocytes and Hep G2 cells: in hepatocytes 36% of total cel- 
lular receptors is present at the cell surface and 39% in Hep 
G2. CURL contains 31 and 37%, respectively, and the total 
Golgi complex, including TGR, contains 23 % in both cases. 
However the amount of receptors present in the Golgi cister- 
nae differ remarkably. In Hep G2 cells, the stacks of Golgi 
cisternae  contain  only  a  small  fraction  (2%)  of the  cell's 
receptors, whereas the Golgi stacks in hepatocytes contain a 
major pool of receptors (14). A corresponding difference be- 
tween  hepatocytes  and  Hep  G2  cells  was  found  for  the 
mannose-6-phosphate receptor (8,  10). The significance of 
this difference is presently unknown. 
We were previously unable to detect an effect of added 
ligand on ASGPR distribution in rat liver parenchymal cells 
after infusion with asialofetuin in vivo for 60 min (9). How- 
ever, as the physiological concentration of ASGPs present in 
the serum is unknown, it is possible that the rate of ligand 
administration in vivo was far below that necessary for satu- 
ration. This problem has been overcome in the present cell 
culture  system.  Using  ASOR,  which  is  a  higher  affinity 
ligand than asialofetuin (19),  we found that the continuous 
administration of a  saturating amount of ligand for 40 min 
resulted in a  14%  decrease of cell  surface receptors and a 
corresponding  increase of receptors in  CURL.  Strikingly, 
the receptor content of TGR remained unchanged, as was the 
case for all other organelles. 
Previous biochemical studies on the ASGPR in Hep G2 
cells (4) have shown that the receptors are able to internalize 
ligand and recycle back to the cell surface every 7  min. In 
the present study we exposed Hep G2 cells to ASOR for 40 
min. Thus most of the receptors on the cell surface had am- 
ple time to complete several cycles of ligand internalization. 
A passage of the 14 % surface receptors through TGR would 
have lead to an increase in TGR receptors during this time 
period.  Since the receptor content of TGR had not signifi- 
cantly increased, in contrast to CURL, these results suggest 
that a major fraction of the surface ASGPRs recycle directly 
from CURL, bypassing the TGR. That a minority of recycling 
surface receptors travel through TGR may well be possible 
since a small increase in TGR receptors may have been over- 
looked. 
A  direct CURL to plasma membrane recycling pathway 
raises the question as to the possible function of the relatively 
large fraction of one-fifth of total cellular receptors present 
in TGR under normal and ligand stimulated conditions. It is 
unlikely that the TGR receptors only represent newly synthe- 
sized molecules in transit to the cell surface. On the basis of 
life time (tt/2  =  30 h) (20) and transit time (45-60 min) (20) 
one can estimate that only 2.5-3.5 % of the cell's receptors 
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Ligand-binding Sites as Determined Biochemically 
Preincubation  Percentage of binding sites 
Percent on 
ASOR  PMQ  Cell surface  Total cell  cell surface* 
-  -  45  ±  5  109  ±  5  41 
+  -  20  ±  1  93  ±  10  22 
-  +  15  ±  1  99  ±  7  15 
+  +  12  ±  1  97  ±  13  12 
Cells were washed and preincubated for 30 min at 37°C with 200 Ilg/ml unla- 
beled ASOR, or 300 laM PMQ, or both. Thereat~er at 4°C, cells were washed 
with PBS without calcium and cell surface receptor was determined by specific 
~2q-ASOR binding as described in Materials and Methods. An identical series 
of dishes  were solubilized  with  saponin  for the  determination  of total  cell 
receptor  as described  in Materials  and  Methods.  Each figure represents  the 
mean  +  SEM of three  determinations. 
* Total specific 12q-ASOR binding for all  12 samples was set to 100%. 
are  present  in  the  entire biosynthetic pathway.  The TGR 
population alone exceeds this figure 10-fold. Therefore, TGR 
receptors likely belong to other pools.  Thus far only the 
"slowly dissociating pool" of ASGPR-ligand complexes (34) 
and the "long transit pool" of ASGPR-ligand complexes (26) 
have been described.  Whether these pools are localized to 
TGR has yet to be investigated. 
In the present study we wished to compare our morpho- 
logic quantitation of receptors with the biochemical determi- 
nation of ligand binding sites.  Previous biochemical studies 
were limited by the inability to determine total cell receptor 
content. In the present study we permeabilized cells with 
saponin and determined the number of cell surface ASOR- 
binding  sites relative to total cell-binding sites.  We found 
that the total number of cell receptors remained unchanged 
under the various conditions considered (Table II). The ratio 
between cell surface and intracellular ligand-binding sites 
was  similar to the surface to internal receptor ratio deter- 
mined immunocytochemically. Thus Hep G2 cells expose 
40 % of their ASGPRs at the cell surface. 
Studies on the effects of weak bases such as chloroquine, 
PMQ,  and NHaC1 have shown that these drugs reduce the 
number of a variety cell surface receptors by inhibiting the 
rate of receptor recycling from intracellular pools of a num- 
ber of receptor species (2,  13, 21, 29,  30).  Kinetic studies 
demonstrated that these effects are rapidly reversible after 
removal of the agents (21). This suggested that the receptors 
accumulate intracellularly in a nonlysosomal compartment. 
We confirmed the dramatic decrease in the number of cell 
surface receptors by PMQ treatment of the cells.  Accord- 
ingly, we found no significant increase in the receptor con- 
tent of lysosomes that were identified by the presence of 
cathepsin D in immuno-double labeling. The most striking 
intracellular accumulation of ASGPRs after PMQ treatment 
occurred in TGR. As defined in this study, TGR is part of 
the pathway of biosynthesis and secretion. CURL, including 
MVBs, displayed a less dramatic accumulation of receptors 
(Table I). The effect of PMQ appeared not to be influenced 
by the presence of additional ASOR.  Besides its effect on 
surface and TGR receptors, PMQ induced an impressive de- 
crease in cell surface area (Figs. 5 and 6) and a simultaneous 
expansion of TGR. 
The effects of ligand and PMQ on intracellular receptor 
distribution  thus  differed  remarkably.  Ligand  challenge 
shifted a fraction of the surface receptors to CURL, whereas 
PMQ treatment almost depleted the cell surface from recep- 
tors in favor of TGR in particular. A possible explanation is 
that PMQ not only inhibited receptor recycling from CURL 
but also induced surface receptors and/or receptors in CURL 
to be transferred to TGR. If so, receptor recycling from TGR 
is apparently blocked as well, resulting in a receptor accu- 
mulation  in  TGR and  an  extension of this  compartment. 
Whether  such  a  connection between  the  endocytotic and 
biosynthetic pathways exists under normal conditions is cur- 
rently under study in our laboratory. It remains to be estab- 
lished whether the PMQ effects were the result of neutraliza- 
tion of acidic compartments or whether additional factors 
were involved. 
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